Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome
暂无分享,去创建一个
R. Gibbs | D. Muzny | S. Plon | Angshumoy Roy | S. Scollon | N. Rainusso | F. Lin | Jacquelyn Reuther | Ilavarasi Gandhi | Kevin E. Fisher | N. Patil | Seema Rao | Hongzheng Dai | S. Gruner | J. Bercaw-Pratt | Lauren Desrosiers | Maren Y. Fuller | D. W. Parsons | Annie Garcia | Lauren R Desrosiers | D. Muzny
[1] P. Concolino,et al. Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli–Leydig Cell Tumor , 2021, Journal of clinical medicine.
[2] W. Foulkes,et al. Somatic tumour testing establishes that bilateral DICER1‐associated ovarian Sertoli–Leydig cell tumours represent independent primary neoplasms , 2020, Histopathology.
[3] Cyrus Chargari,et al. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors. , 2018, The oncologist.
[4] D. Rakheja,et al. Distinct DICER1 Hotspot Mutations Identify Bilateral Tumors as Separate Events , 2018, JCO Precision Oncology.
[5] Jubilee Brown,et al. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. , 2017, Gynecologic oncology.
[6] W. Foulkes,et al. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors , 2017, The American journal of surgical pathology.
[7] Steven J. M. Jones,et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. , 2012, The New England journal of medicine.